Methods and devices for diagnosis of particles in biological fluids

Patent metadata

Field	Value
Publication number	US-10059978-B2
Application number	US-201414897432-A
Country	US
Kind code	B2
Filing date	Jun 11, 2014
Priority date	Jun 11, 2013
Publication date	Aug 28, 2018
Grant date	Aug 28, 2018

Abstract

Methods for determining whether certain compounds, in particular crystals, are present in a sample of a biological fluid that indicates an individual has a particular disease or condition, such as but not limited to gout, pseudogout or urinary tract stones. In some embodiments, the methods include the steps of digestion and filtration of a sample of synovial fluid in order to isolate, if present, monosodium urate monohydrate (MSU), calcium pyrophosphate dihydrate (CPPD), or calcium phosphate crystals from the sample, wherein the filtrate is analyzed with a Raman device to ascertain the presence and type of the crystals. Devices for performing steps of the method are disclosed.

First claim

What is claimed is:

1. A method for diagnosing tor one or more of kidney stones, gout and pseudogout, comprising the steps of:
a) obtaining a sample of a biological fluid;
b) performing digestion of the fluid to release crystals or particles in the fluid;
c) filtering the digested fluid to recover the released crystals or the particles;
d) analyzing the released and filtered crystals or the particles with a diagnostic device, and
e) determining if gout-causing or pseudogout-causing crystals or kidney stones are present, wherein analyzing the crystals comprises the use of a Raman device, wherein the Raman device acquires spectra from a plurality of different points on the released crystals, and wherein the spectrum acquired at each point is processed to remove background fluorescence, subtract a filter related peak and identify crystal species present.

2. The method according to claim 1 , wherein performing digestion includes supplementing the fluid with a compound that is adapted to at least partially release the crystals from organic debris present in the fluid.

3. The method according to claim 2 , wherein the compound includes a glycosaminoglycan-cleaving enzyme and a protein-cleaning enzyme, wherein the fluid is first supplemented with the glycosaminoglycan-cleaving enzyme and thereafter supplemented with the protein-cleaving enzyme.

4. The method according to claim 3 , wherein glycosaminoglycan-cleaving enzyme comprises hyaluronidase, and wherein the protein-cleaving enzyme comprises proteinase K.

5. The method according to claim 1 , wherein the biological fluid is urine or synovial fluid.

6. A method for diagnosing for one or more of kidney stones, gout and pseudogout, comprising the steps of:
a) obtaining a sample of a biological fluid;
b) performing digestion of the fluid to release crystals or particles in the fluid;
c) filtering the digested fluid to recover the released crystals or the particles; and
d) analyzing the released and filtered crystals or the particles with a diagnostic device, and e) determining if gout-causing or pseudogout-causing crystals or kidney stones are present, wherein the compound includes a glycosaminoglycan-cleaving enzyme and a protein-cleaning enzyme, wherein the fluid is first supplemented with the glycosaminoglycan-cleaving enzyme and thereafter supplemented with the protein-cleaving enzyme, wherein glycosaminoglycan-cleaving enzyme comprises hyaluronidase, and wherein the protein-cleaving enzyme comprises proteinase K.

7. The method according to claim 6 , wherein performing digestion includes supplementing the fluid with a compound that is adapted to at least partially release the crystals from organic debris present in the fluid, wherein the compound includes a detergent.

8. The method according to claim 7 , wherein analyzing the crystals comprises the use of a Raman device.

9. The method according to claim 8 , wherein the Raman device acquires spectra from a plurality of different points on the released crystals, wherein the spectrum acquired at each point is processed to remove background fluorescence, subtract a filter related peak and identify crystal species present.

10. The method according to claim 6 , wherein the biological fluid is urine or synovial fluid.

Assignees

• Univ Case Western Reserve

Inventors

• Akkus Ozan
• Slipchenko Mikhail
• Akkus Anna
• Yang Shan
• Li Bolan

Classifications

• G01N2800/107

  Crystal induced conditions; Gout · CPC title

• G01N2001/4088

  filtration · CPC title

• C12Q1/40 Primary

  involving amylase · CPC title

• G01N1/4077

  by other techniques involving separation of suspended solids · CPC title

• G01N2333/958

  derived from fungi · CPC title